CSIMarket
 
China Pharma Holdings Inc  (NYSEAMER: CPHI)
 

China Pharma Holdings Inc's Suppliers Performance

CPHI's Supply Chain




 
CPHI Costs vs Sales of Suppliers Growth China Pharma Holdings Inc's cost of sales deteriorated by -22.29 % year on year, sequentially cost of sales grew by 23.88 % in Q2.

• More on CPHI Suppliers



China Pharma Holdings Inc's cost of sales deteriorated by -22.29 % year on year, sequentially cost of sales grew by 23.88 % in Q2.

• More on CPHI Suppliers




China Pharma Holdings Inc's Comment on Supply Chain


Helpson sources a wide range of raw materials for its manufacturing processes, supported by a purchasing team that works closely with product development and quality control departments. The company maintains relationships with multiple suppliers both within the PRC and internationally, ensuring at least three principal suppliers for each critical raw material. For the year ended December 31, 2025, the top three suppliers accounted for 26.6%, 26.3%, and 9.6% of raw material purchases, respectively. For the year ended December 31, 2024, these figures were 22.9%, 21.3%, and 14.6%, respectively. Helpson has not historically encountered difficulties in obtaining raw materials from its suppliers.

China Pharma Holdings Inc's Comment on Supply Chain


Helpson sources a wide range of raw materials for its manufacturing processes, supported by a purchasing team that works closely with product development and quality control departments. The company maintains relationships with multiple suppliers both within the PRC and internationally, ensuring at least three principal suppliers for each critical raw material. For the year ended December 31, 2025, the top three suppliers accounted for 26.6%, 26.3%, and 9.6% of raw material purchases, respectively. For the year ended December 31, 2024, these figures were 22.9%, 21.3%, and 14.6%, respectively. Helpson has not historically encountered difficulties in obtaining raw materials from its suppliers.







CPHI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
China Pharma Holdings Inc 30.46 3.91 -4.47 221
SUBTOTAL 0.00 0.00 0.00 -


Sources: China Pharma Holdings Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on China Pharma Holdings Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.